Status:
TERMINATED
NAVIGATE GRX Study
Lead Sponsor:
Corindus Inc.
Conditions:
Coronary Artery Disease
Eligibility:
All Genders
20+ years
Brief Summary
The objective of the present study is to detail the results of robotic-assisted PCI using technIQ automated movements in real-world clinical practice.
Detailed Description
This multi-center, international, randomized, open-label, post-market study will enroll subjects to detail the results of robotic-assisted PCI using technIQ automated movements in real-world clinical ...
Eligibility Criteria
Inclusion
- Male or nonpregnant female aged ≥ 20 years.
- Patients with coronary artery disease with clinical indication for Percutaneous Coronary Intervention (PCI).
- The subject has been informed of the nature of the study, agrees to its provisions and has provided written informed consent.
Exclusion
- Failure/inability/unwillingness to provide informed consent.
- In the opinion of the investigator, the subject is deemed unsuitable for robotic PCI due to clinical status or anatomic characteristics.
- Acute STEMI within 72 hours pre-procedure.
Key Trial Info
Start Date :
June 14 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 7 2022
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04883008
Start Date
June 14 2021
End Date
February 7 2022
Last Update
December 20 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Intercard Sp. Z o.o.
Nowy Sącz, Poland